Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
eli lilly
5
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
fda
san francisco blog main
blueprint medicines
indiana blog main
indiana top stories
national top stories
san francisco top stories
amgen
avapritinib
boston
calcitonin gene-related peptide
cancer
cancer drugs
chronic migraine
episodic migraine
europe blog main
genentech
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
roche
selpercatinib
teva pharmaceutical
thyroid cancer
alder biopharmaceuticals
black diamond therapeutics
bladder cancer
boulder/denver blog main
boulder/denver top stories
capmatinib
cstone pharmaceuticals
david rind
What
drug
5
×
medicines
5
×
approval
fda
cancer
new
blueprint
class
developed
migraine
pain
ret
starts
won
address
amgen
announced
approved
approves
biotech
black
candidate
candidates
carries
certain
clinic
companies
currently
decision
designed
diamond
eli
eluded
genetic
gets
head
headache
hopes
ipo
late
Language
unset
Current search:
drug
×
biotech
×
" eli lilly "
×
medicines
×
@xconomy.com
4 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines